Monday, September 30, 2013

Hot or Not? Small Cap Internet, App or Digital Signage Stocks: BLAP, TGFN & DCLT

Small cap small cap Internet, app or digital signage stocks Blast Applications, Inc (OTCMKTS: BLAP), TGFIN Holdings Inc (OTCMKTS: TGFN) and Data Call Technologies, Inc (OTCMKTS: DCLT) were getting some extra attention last week. Specifically, two of these stocks have been the subject of paid promotions while the third surged 114.29% on Friday. With that in mind, here is a closer look along with a reality check on all three small cap stocks:

Blast Applications, Inc (OTCMKTS: BLAP) Announced $10 Million in Financing Last August

Small cap Blast Applications is a marketer and developer of applications for Android, iPhone®, Twitter® Facebook® and Nokia with unique opportunity to monetize the web surfer's dedication to social media sites through direct advertising programs tied to the Company's tools, applications and websites. On Friday, Blast Applications rose 4.67% to $0.0157 for a market cap of $8.57 million plus BLAP is up 124.3% over the past year and down 94.6% over the past five years according to Google Finance.

z?s=BLAP&t=5d&q=&l=&z=l&a=v&p=s&lang=en-

What's the Catch With Blast Applications? According to various disclosures, transactions of $10k and $15k have or will occur to mention Blast Applications in various investment newsletters. Last Tuesday, Blast Applications issued a quick investor update which noted the company has "expended its range nationally and internationally" plus they are in the process of signing a contract for the launch of Tobi Rubinstein Schneier's Reality TV show on http://www.galaxyglobaltv.com which will also be available nationally on the Dish Network on Demand - reaching 14 million subscribers. Otherwise and back in August, Blast Applications announced it had received a $10,000,000 Reserve Equity Financing Facility from AGS Capital Group, LLC, a US based private investment fund. The financing would be subject to being registered with the SEC as well as other conditions. A quick look at Blast Applications' financials reveals revenues of $41k (most recent reported quarter), $39k, negative $68k and $113k for the past four quarters plus net losses of $49k (most recent reported quarter) and $54k, net income of $95k and a net loss of $156k. At the end of June, Blast Applications had $3k in cash to cover $1,518k in total liabilities – meaning the $10 million in financing would be a game changer.

TGFIN Holdings Inc (OTCMKTS: TGFN) Surged 114.29% Last Friday

Small cap TGFIN Holdings develops software applications for the Apple iphone and other hand-held devices in the United States. Its applications include SportsCast Baseball, SportsCast Basketball, and SportsCast Soccer. The company sells its applications online at the Apple Store. On Friday, TGFIN Holdings surged 114.29% to $0.0270 for a market cap of $629,668 plus TGFN is up 116% over the past year and down 10% over the past five years according to Google Finance.

z?s=TGFN&t=5y&q=l&l=on&z=l&a=v&p=s&lang=

What's the Catch With TGFIN Holdings? According to various disclosures, no transactions have occurred to mention TGFIN Holdings in various investment newsletters. I am not seeing any news on the financial wires to explain the sudden surge of TGFIN Holdings on Friday nor the spike shares had last Monday. A quick look at TGFIN Holdings' financials reveals no revenues; net income of $234k and net losses of $30k, $305k and $16k for the past four quarters; and $34k in cash to cover $196k in current liabilities at the end of June. So its hard to explain why TGFIN Holdings' shares have suddenly become active last week.

Data Call Technologies, Inc (OTCMKTS: DCLT) Has No Recent News

Small cap Data Call Technologies was created in 2002 just as Digital Signage began to stake its claim in the world of advertising. The company aims to integrate cutting-edge information delivery solutions that are currently deployed by the media, and put them within the control of retail and commercial enterprises. On Friday, Data Call Technologies fell 14.7% to $0.0145 for a market cap of $521,658 plus DCLT is down 73.6% over the past year and down 85.5% over the past five years according to Google Finance.

z?s=DCLT&t=2y&q=&l=&z=l&a=v&p=s&lang=en-

5 Best Gold Stocks To Invest In 2014

What's the Catch With Data Call Technologies? According to various disclosures, transactions of $5k and $35k have or will occur to mention Data Call Technologies in various investment newsletters. Data Call Technologies has been rather quiet with the press releases lately as the last press release in early August announced the launch of the Direct Lynk Media product and the launch of its newly revamped website (www.datacalltech.com). Otherwise and despite the recent promotions, there has not been much news since the spring time. A quick look at Data Call Technologies' financials reveals revenues of $157k (most recent reported quarter), $157k, $123k and $124k for the past four quarters along with net losses of $1k and $130k and net income of $3k and zero. As of the end of June, Data Call Technologies had $64k in cash to cover $294k in current liabilities. Those financials are not overly exciting; but given the promotions, maybe we can expect some new news to get the stock going again Data Call Technologies.

Sunday, September 29, 2013

Top 10 Performing Stocks To Own Right Now

Shares of Sealed Air Corporation (SEE) hit a new 52-week high of $27.65 on Jul 12, surpassing its previous high of $27.27. The company has delivered a robust one-year return of about 84.4% and year-to-date return of 58.9%, outperforming the S&P 500.

The Elmwood Park, NJ-based specialty packaging service provider has long-term estimated earnings per share growth rate of 12.9%. Average volume of shares traded over the last three months is approximately 1913K.

What�� Driving Sealed Air Up?

Sealed Air reported first-quarter 2013 adjusted net earnings from continuing operations of 17 cents per share, up 6% from the year-ago earnings of 16 cents per share but a penny short of the Zacks Consensus Estimate.

Although earnings missed estimates, Sealed Air declared an improved outlook for full year 2013. The company expects adjusted earnings in the range of $1.10 to $1.20 per share on net sales of $7.7��7.9 billion. Furthermore, adjusted EBITDA is expected in the range of $1.01��1.03 billion.

Top 10 Performing Stocks To Own Right Now: Zillow Inc (Z.O)

Zillow, Inc. (Zillow), incorporated on December 13, 2004, is a real estate and home-related information marketplaces. Zillow provides products and services to help consumers through every stage of homeownership buying, selling, renting, borrowing and remodeling. The Company make home-related decisions, and enabling homeowners, buyers, sellers and renters to find and connect with local professionals. Individuals and businesses that use Zillow have updated information on more than 37 million homes and have added nearly 100 million home photos. These profiles include detailed information about homes such as property facts, listing information, and purchase and sale data. In June 2012, the Company acquired RentJuice Corporation. In October 2012, the Company acquired Buyfolio, an online and mobile collaborative shopping platform. In December 2012, the Company acquired San Francisco-based HotPads, a map-based rental and real estate search site.

Zillow generates r evenues from local real estate professionals, primarily on an individual subscription basis, and from mortgage professionals and brand advertisers. The Company�� revenues include marketplace revenues, consisting of subscriptions sold to real estate agents and advertising sold on a cost per click (CPC) basis to mortgage lenders, and display revenues consisting of advertising placements sold primarily on a cost per thousand impressions (CPM) basis. The Company provides current home value estimates, or Zestimates, and current rental price estimates, or Rent Zestimates, on approximately 100 million United States homes.

Marketplace Revenues

Marketplace revenues consist of subscriptions sold to real estate agents under its Premier Agent program and CPC advertising related to the Company�� Zillow Mortgage Marketplace sold to mortgage lenders. The Company�� premier agent program offers a suite of marketing and business technology solutions to help re al estate agents grow their businesses and personal brands! . ! The premier agent program allows agents to select products and services that they can tailor to meet their business and advertising needs. In Zillow Mortgage Marketplace, participating qualified mortgage lenders make a prepayment to gain access to consumers interested in connecting with mortgage professionals. Consumers who request rates for mortgage loans in Zillow Mortgage Marketplace are presented with personalized lender quotes from participating lenders. The Company charges mortgage lenders a fee when users click on their links for more information regarding a mortgage loan quote. Mortgage lenders who exhaust their initial prepayment can then prepay additional funds to continue to participate in the marketplace.

Display Revenues

Display revenues primarily consist of graphical Web and mobile advertising sold on a CPM basis to advertisers primarily in the real estate industry, including real estate brokerages, home builders, mortgage lenders and home services providers. The Company�� advertising customers also include telecommunications, automotive, insurance and consumer products companies.

Top 10 Performing Stocks To Own Right Now: Arc Capital Holdings Ltd (ARCH)

ARC Capital Holdings Limited (ARCH) is a closed-end investment company. ARCH�� investment objective is to provide its shareholders with capital appreciation by investing in listed and unlisted companies in the retail, consumer goods and consumer service sectors principally in China and in neighbouring Asian countries. The Company may also finance such companies for expansion through buy-outs, pre-initial public offering (IPO) opportunities and other equity and mezzanine securities. At least 70% of the Company�� gross assets will be invested in China. Up to a maximum of 30 % of the Company�� gross assets may also be invested in Greater China and other countries in Asia. The Company may invest in equity, quasi-equity or debt instruments, which may or may not represent shareholding or management control. ARCH is managed by ARC Capital Partners Limited.

10 Best Value Stocks To Own Right Now: Reef Casino Trust (RCT.AX)

Reef Casino Trust owns and leases The Reef Hotel Casino complex located in Cairns, Australia. The Reef Hotel Casino complex consists of a casino, which includes table games and approximately 500 electronic gaming machines; a 5 star hotel with 128 luxury guest rooms and suites, as well as with rooftop swimming pool, sauna, and a gymnasium; and various facilities, such as bars, conference and banqueting facilities, spas, sports arena, and a nightclub. The company was founded in 1993 and is based in Brisbane, Australia. Reef Casino Trust is a subsidiary of Reef Casino Investments Pty Ltd.

Top 10 Performing Stocks To Own Right Now: Bevo Agro Inc. (BVO.V)

Bevo Agro Inc., through its subsidiary, Bevo Farms Ltd., engages in the propagation of vegetable plants to greenhouse growers, nurseries, and retailers in North America. The company operates 34 acres of propagation greenhouse facilities on 98 acres of land in Milner, British Columbia; and provides vegetable plants, such as tomatoes, peppers, and cucumbers, as well as offers other plants comprising bedding plants, flowers, trees, cranberries, grasses, and poinsettias. It also produces cucumbers, which are marketed and sold through a licensed marketing agency. The company was incorporated in 1985 and is based in Milner, Canada.

Top 10 Performing Stocks To Own Right Now: Access National Corp (ANCX)

Access National Corporation (ANC) operates as a bank holding company. The Company has two wholly owned subsidiaries: Access National Bank (the Bank) and Access National Capital Trust II. The Bank is the operating business of the Company. The Bank provides credit, deposit, and mortgage services to middle market commercial businesses and associated professionals, primarily in the greater Washington, D.C. Metropolitan Area. The Bank offers a range of financial services and products and specializes in providing customized financial services to small and medium sized businesses, professionals, and associated individuals. The Bank provides its customers with personal customized service utilizing the latest technology and delivery channels. The Bank�� business is serving the credit, depository and cash management needs of businesses and associated professionals. The products and services offered by the Bank include accounts receivable lines of credit, accounts receivable collection accounts, growth capital term loans, business acquisition financing, online banking, checking accounts, money market accounts, sweep accounts, personal checking accounts, savings /money market accounts and certificates of deposit.

The Bank�� revenues are derived from interest and fees received in connection with loans, deposits, and investments. The Bank operates from five banking centers located in Chantilly, Tysons Corner, Reston, Leesburg and Manassas, Virginia and online at www.accessnationalbank.com. The Mortgage Corporation specializes in the origination of conforming and government insured residential mortgages to individuals in the greater Washington, D.C. Metropolitan Area, the surrounding areas of its branch locations, outside of its local markets through direct mail solicitation, and otherwise. The Mortgage Corporation has offices throughout Virginia, in Fairfax, Reston, Roanoke, and McLean.

Lending Activities

The Bank�� lending activities involve commercial real estate loa! ns, residential mortgage loans, commercial loans, commercial and residential real estate construction loans, home equity loans, and consumer loans. These lending activities provide access to credit to small to medium sized businesses, professionals, and consumers in the greater Washington, D.C. Metropolitan Area. Loans originated by the Bank are classified as loans held for investment. At December 31, 2011 loans held for investment totaled $569.4 million. At December 31, 2011 unsecured loans were comprised of $2.9 million in commercial loans and approximately $124 thousand in consumer loans and collectively equal approximately 0.5% of the loans held for investment portfolio.

The Bank�� commercial real estate loans-wner Occupied represented 30.14% of our loan portfolio held for investment, as of December 31, 2011. Its commercial real estate loans-non-owner occupied loans represent ed18.44% of its loan portfolio held for investment, as of December 31, 2011. The Bank�� residential real estate loans represented 22.56% of the loan portfolio, as of December 31, 2011.

These loans fall into one of three situations: loans supporting an owner occupied commercial property; properties used by non-profit organizations, such as churches or schools where repayment is dependent upon the cash flow of the non-profit organizations, and loans supporting a commercial property leased to third parties for investment. Its residential real estate loans category includes loans secured by first or second mortgages on one to four family residential properties, extended to the Bank clients.

As of December 31, 2011, commercial loans represented 23.15% of the Bank�� loan portfolio held for investment. These loans are to businesses or individuals within its market for business purposes. As of December 31, 2011, real estate construction loans consisted of 5.22% of loans held for investment loan portfolio. These loans include loans to construct owner occupied commercial buildings; l! oans to i! ndividuals; loans to builders for the purpose of acquiring property and constructing homes for sale to consumers, and loans to developers for the purpose of acquiring land, which is developed into finished lots for the ultimate construction of residential or commercial buildings. As of December 31, 2011, consumer loans made up approximately 0.49% of its loan portfolio.

Investment Activities

The Company�� investment securities portfolio is consisted of the United States Treasury securities, the United States Government Agency securities, municipal securities, Community Reinvestment Act (CRA) mutual fund, and mortgage backed securities issued by the United States Government sponsored agencies and corporate bonds. At December 31, 2011, securities totaled $85.8 million. . The securities portfolio is comprised of $45.8 million in securities classified as available-for-sale and $40.0 million in securities classified as held-to-maturity.

Sources of Funds

As of December 31, 2011, deposits totaled $645.0 million. As of December 31, 2011, deposits consisted of noninterest-bearing demand deposits in the amount of $113.9 million, savings and interest-bearing deposits in the amount of $182.0 million, and time deposits in the amount of $349.1 million. The Bank also uses wholesale funding or brokered deposits to supplement traditional customer deposits for liquidity. It participates in the Certificate of Deposit Account Registry Service (CDARS). Through CDARS its depositors are able to obtain FDIC insurance of up to $50 million. As of December 31, 2011, brokered deposits totaled $223,554,000, which includes $192,326,000 in reciprocal CDARS deposits. It also maintains lines of credit with the Federal Home Loan Bank (FHLB) and Federal Reserve Bank (FRB). At December 31, 2011 there was $284.9 million available under these lines of credit. Borrowed funds consist of advances from the FHLB, senior unsecured term note, FHLB long-term borrowings, subordinated debentures (! trust pre! ferred), securities sold under agreement to repurchase, United States Treasury demand notes, federal funds purchased, and commercial paper. As of December 31, 2011 borrowed funds totaled $123.6 million. At December 31, 2011 borrowed funds totaled $70.9 million.

Top 10 Performing Stocks To Own Right Now: Ellipsiz Ltd (E13.SI)

Ellipsiz Ltd., an investment holding company, provides probe card, distribution, and service solutions to the semiconductor, electronics manufacturing, and telecommunication industries. The company�s Distribution and Services Solutions segment engages in the distribution of equipment and tools for semiconductor and electronics manufacturing, integrated circuit (IC) failure analysis, IC reliability testing, and printed circuit board assembly testing and inspection; and provision of equipment maintenance support engineering services, including systems integration. This segment also provides facilities management services comprising turnkey facilities hookup and turnkey wafer fabrication equipment relocation, as well as chemicals, gas, and abatement management services; test characterization services, such as qualification and reliability testing; and refurbishment services for pumps used in wafer fabs, as well as trades in consumable products for hospital, pharmaceutical, e lectronic, and food processing industries. The company�s Probe Card Solutions segment is involved in the design, manufacture, repair, and sale of probe card solutions for the semiconductor manufacturing industry. It operates in Singapore, Malaysia, China, Thailand, the Philippines, Taiwan, Vietnam, India, Japan, New Zealand, Europe, and the United States. The company was formerly known as SingaTrust Ltd. and changed its name to Ellipsiz Ltd. in 2001. Ellipsiz Ltd. was founded in 1992 and is headquartered in Singapore.

Top 10 Performing Stocks To Own Right Now: Ku6 Media Co. Ltd.(KUTV)

Ku6 Media Co., Ltd. operates as an online video company in the People?s Republic of China. It operates ku6.com, an online video portal that provides news, reports, and other interactive entertainment programs for its users, as well as offers a video platform for sharing and watching user-generated content. The company also operates juchang.com that provides copyrighted content, such as movies, television series, and other video programs sourced from its content partners. In addition, it offers Internet audio solutions, including online radio channels, built-in radio for online games, and other services to customers through its online audio advertising business. The company is based in Beijing, China.

Top 10 Performing Stocks To Own Right Now: Myriad Genetics Inc (MYGN)

Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis. The Company uses this information to guide the development of new molecular diagnostic tests that are designed to assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to ensure optimal treatment (personalized medicine), or assess a patient's risk of disease progression and disease recurrence (prognostic medicine).

As of June 30, 2012, the Company had launched nine commercial molecular diagnostic tests. The Company markets these tests through its own approximate 385-person sales force in the United States. The Company also markets its BRACAnalysis, COLARIS, and COLARIS AP tests through its own European sales force and have entered into marketing collaborations with other organizations in selected Latin American, European and Asian countries. The Company also generates revenue by providing companion diagnostic services to the pharmaceutical, and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.

Molecular Diagnostic Tests

The Company's molecular diagnostic tests are designed to analyze genes, their mutations, expression levels and proteins to assess an individual's risk for developing disease later in life, determine a patient's likelihood of responding to a particular drug, assess a patient's risk of disease progression and disease recurrence and measure a patient's exposure to drug therapy to ensu! re optimal dosing and reduced drug toxicity. The Company's BRACAnalysis test is a analysis of the BRCA1 and BRCA2 genes for assessing a woman's risk of developing hereditary breast and ovarian cancer. BRACAnalysis accounted for 81.7% of the Company's total revenue during the fiscal year ended June 30, 2012. Its The Company's COLARIS test is an analysis of the MLH1, MSH2, MSH6 and PMS2 genes for assessing a person's risk of developing colorectal cancer or uterine cancer.

The Company's COLARIS AP test detects mutations in the APC and MYH genes, which cause a colon polyp-forming syndrome known as Familial Adenomatous Polyposis (FAP), a more common variation of the syndrome known as attenuated FAP, and the MYH-associated polyposis signature (MAP). The Company's MELARIS test analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma. The Company's OnDose test is a nanoparticle immunoassay that is designed to assist oncologists in optimizing 5-FU (fluorouracil) anti-cancer drug therapy in colon cancer patients on an individualized basis. The Company's PANEXIA test is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. The Company's PREZEON test is an immunohistochemistry test that analyzes the PTEN gene and assesses loss of PTEN function in many cancer types.

The Company's Prolaris test is a 46-gene molecular diagnostic assay that assesses whether a patient is likely to have a slow growing, indolent form of prostate cancer that can be safely monitored through active surveillance, or a more aggressive form of the disease that would warrant aggressive intervention, such as a radical prostatectomy or radiation therapy. The Company's TheraGuide 5-FU test analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of toxicity to 5-FU (fluorouracil) anti-cancer drug therapy.

Companion Diagnostic Services and Other Revenue

! Through M! yriad RBM Inc., the Company provides biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical researches industries utilizing its multiplexed immunoassay technology. The Company's technology enables the Company to screen large sets of clinical samples from both diseased and non-diseased populations against the Company's menu of biomarkers. The Company's companion diagnostic services consist of Multi-Analyte Profile (MAP), Multiplexed Immunoassay Kits and TruCulture.

The Company has compiled a library of over 550 individual human and rodent immunoassays for use in its multi-analyte profile (MAP) testing services. The Company has also developed RodentMAP, a panel for use in pre-clinical animal studies and OncologyMAP, which measures cancer-related proteins to assists researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring. The Company has developed multiplexed immunoassay kits that enable its customers to leverage its technology services with their in-house capabilities. The Company's internally developed multiplexed immunoassay kits include all of the components necessary for a customer to perform a test on their own Luminex instrument. TruCulture is a simple, self-contained whole blood culture that can be deployed to clinical sites around the world for acquiring cell culture data without specialized facilities or training.

Top 10 Performing Stocks To Own Right Now: Loring Ward Intl Ltd (LW.TO)

Leisureworld Senior Care Corp., through its subsidiaries, provides long-term care (LTC) services in Ontario, Canada. As of July 17, 2012, it owned and operated 27 LTC homes in Ontario with 4,474 beds; and 6 retirement residences and 1 independent living residence in Ontario and British Columbia. The company�s homes provide professional nursing and personal support services for community-based home healthcare and LTC homes; and purchasing services, as well as dietary, social work, and other regulated health professional services to homes. It provides long-term care homes for people who do not need to be in a hospital but can not be cared for at home or in an assisted living facility due to illness, injury, frailty, or other limitations. Leisureworld Senior Care Corp. was founded in 1972 and is headquartered in Markham, Canada.

Top 10 Performing Stocks To Own Right Now: Flextronics International Ltd.(FLEX)

Flextronics International Ltd. provides design and electronics manufacturing services to original equipment manufacturers. The company offers its services to a range of products in the infrastructure, mobile communication devices, computing, consumer digital devices, industrial, semiconductor capital equipment, clean technology, aerospace and defense, white goods, automotive and marine, and medical devices markets. Its services include design and engineering services, such as contract design, joint development manufacturing, and original design and manufacturing services in a range of technical competencies that include system architecture, user interface and industrial design, mechanical engineering, enclosure systems, thermal and tooling design, electronic system design, reliability and failure analysis, and component level development engineering; and systems assembly and manufacturing services, including enclosures, testing, and materials procurement and inventory mana gement services. The company also offers various component product solutions comprising rigid and flexible printed circuit board fabrication, display and touch solutions, optomechatronics, and power supplies; after market supply chain logistics services; and reverse logistics and repair services, such as returns management, exchange programs, complex repair, asset recovery, recycling, and e-waste management services for consumer and midrange products, printers, PDA's, mobile phones, consumer medical devices, notebooks, PC's, set-top boxes, game consoles, and infrastructure products. It has operations in Asia, the Americas, and Europe. Flextronics International Ltd. was founded in 1990 and is headquartered in Singapore.

Advisors' Opinion:
  • [By Amber Hestla, Michael J. Carr]

    Among its suppliers is Flextronics International (Nasdaq: FLEX), which offers a variety of engineering services and provides supply chain management. Other Flextronics customers include Hewlett-Packard (NYSE: HPQ), LG and Google's (Nasdaq: GOOG) Motorola Mobility. 

Saturday, September 28, 2013

September Farm Prices Continue Downward Trend

The U.S. Department of Agriculture (USDA) released its preliminary report on September farm prices on Friday afternoon. The September all-products price index dropped by 4 points (2.1%) to 185 month-over-month, with the crop index down 3.7% and the livestock index down 0.6%. The preliminary all-products index is down 5.1% year-over-year. The index uses prices from 1990-1992 as its base value (100). The monthly declines are smaller than the July to August declines.

The USDA noted that increased sales of cattle, milk, and calves offset lower sales of wheat, corn, and hogs.

Farm costs, measured by the prices paid index fell 1.4% month-over-month to 213, and that's 1.8% lower than September of 2012. Lower prices for nitrogen fertilizer, feed grains, and other fertilizers offset higher prices for feeder cattle, diesel fuel, and LP gas.

Top Blue Chip Stocks To Watch Right Now

Prices received by farmers rose the most for fruits and nuts (up 8.3% from August) and dairy products (up 2%). Feed grains and hay, commercial vegetables, and potatoes and dry beans were all lower month-over-month. Compared with September 2012, commercial vegetables prices are a 9.3% lower than a year ago.

Meat prices are up 7.1% year-over-year, with hogs up about 24% and beef cattle up about 1.6%. Live cattle prices have been on a steep climb since mid-month as U.S. supplies continue to slide while producers build back their herds. Retail beef prices are expected to stay high for the next month at least.

Here is how some agriculture-related ETFs are performing today:

The Market Vectors Agribusiness ETF (NYSEMKT: MOO) was trading down about 1% before the USDA report was released. About half an hour before markets close today shares are down about 1% at $51.64 in a 52-week range of $48.75 to $56.55.

The PowerShares DB Agriculture fund (NYSEMKT: DBA) was trading down about 0.2% before the report, and remained flat at $25.44, in a 52-week range of $24.36 to $29.64.

The Teucrium Corn Fund (NYSEMKT: CORN) traded down about 0.4% and fell to down 0.5% at $34.30 in a 52-week range of $33.95 to $49.34.

The Teucrium Wheat Fund (NYSEMKT: WEAT) was trading flat before the report, and rose to $16.92, up 0.5% in a 52-week range of $24.36 to $29.64.

Friday, September 27, 2013

Dunkin' Should Be Bought For Future Earnings And Dividend Growth

Dunkin' Brands Group (DNKN) is a franchiser of quick service restaurants serving hot and cold coffee and baked goods, as well as hard serve ice cream in the form of Dunkin' Donuts and Baskin-Robbins, respectively. On July 25, 2013, the company reported second quarter earnings of $0.41 per share, which beat the consensus of analysts' estimates by $0.01. In the past year the company stock is up 41.71% excluding dividends (up 43.6% including dividends), and is beating the S&P 500, which has gained 15.92% in the same time frame. With all this in mind I'd like to take a moment to evaluate the stock on a fundamental, financial, and technical basis to see if it's worth buying more shares of the company right now for the services sector of my dividend growth portfolio.

Fundamentals

The company currently trades at a trailing 12-month P/E ratio of 37.32, which is expensively priced, but I mainly like to purchase a stock based on where the company is going in the future as opposed to what it has done in the past. On that note, the 1-year forward-looking P/E ratio of 23.99 is currently fairly priced for the future in terms of the right here, right now. The 1-year PEG ratio (1.99), which measures the ratio of the price you're currently paying for the trailing 12-month earnings on the stock while dividing it by the earnings growth of the company for a specified amount of time (I like looking at a 1-year horizon), tells me that the company is fairly priced based on a 1-year EPS growth rate of 18.72%.

Financials

On a financial basis, the things I look for are the dividend payouts, return on assets, equity and investment. The company pays a dividend of 1.74% with a payout ratio of 65% of trailing 12-month earnings while sporting return on assets, equity and investment values of 4.1%, 37.7% and 8.2%, respectively, which are all respectable values. The really high return on equity value (37.7%) is an important financial metric for purposes of comparing the profitability which is generated wit! h the money shareholders have invested in the company to that of other companies in the same industry. For comparison, Dunkin' has the third highest ROE out of 12 companies in the mid-cap restaurants industry. It is behind Brinker International (EAT) which has a value of 71.4% and Bloomin' Brands (BLMN) which has a value of 43.5%. Because I believe the market may get a bit choppy here and would like a safety play, I don't believe the 1.74% yield of this company is good enough for me to take shelter in for the time being if I were to initiate a new position.

Technicals

(click to enlarge) Looking first at the relative strength index chart (RSI) at the top, I see the stock near middle ground territory with a value of 45.74 but with downward trajectory, which is a bearish pattern. To confirm that, I will look at the moving average convergence-divergence (MACD) chart next and see that the black line is below the red line with the divergence bars increasing in height to the downside, indicating the stock has downward momentum. As for the stock price itself ($43.66), I'm looking at the 20-day moving average to act as resistance and $42.01 to act as support for a risk/reward ratio, which plays out to be -3.78% to 1%.

Recent News

The company says it will add 17 locations in the western and central part of Texas as it continues to it's "Manifest Destiny" as I dub it. This will help the company bring in additional revenue.On top of domestic expansion, the company announced that it plans to re-sow some seeds in the United Kingdom.

Conclusion

Dunkin' is fairly valued based on future earnings. Financially, the dividend payout ratio is middle of the road based on trailing 12-month earnings. I don't doubt management will be able to continue to increase the dividend going forward. Based on future earnings the dividend payout ratio goes down to around 41.8% (if the dividend is kept s! teady). T! he technical situation of how the stock is currently trading is telling me we might be seeing some downward pressure in the immediate future strictly based on the stock having downward trajectory on both the RSI and MACD charts. The high future earnings growth estimates, high return on equity, and potential for future dividend growth are what I like about the company. Personally I'm going to layer a small position right here only because I believe I can get it at a cheaper price very soon.

Disclaimer: These are only my personal opinions and you should do your own homework. Only you are responsible for what you trade and happy investing!

Source: Dunkin' Should Be Bought For Future Earnings And Dividend Growth

Disclosure: I am long DNKN. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)

Thursday, September 26, 2013

My 4 Favorite High-Yield Large Caps with Buy Rating and 9 Additional to Consider

Today I would like to give you an update of the higher capitalized stocks with buy ratings by brokerage firms. I personally prefer stocks with lower yields and better growth perspectives because I don't need high yields to live off of.

Only 13 stocks fulfilled these two criteria but the most of the results have an extraordinary high debt. It's very risky to buy stocks with large amounts of debt because debt owners get money before share owners. If trouble should develop, the dividends must keep flat or be reduced.

Stocks from the basic material sector as well as telecoms are the dominating categories. But there are also some good names on the list like Williams Partners or Altria.

Here are my favorite stocks:

Williams Partners (WPZ) has a market capitalization of $22.97 billion. The company employs 3,658 people, generates revenue of $7.320 billion and has a net income of $1.232 billion. Williams Partners's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2.273 billion. The EBITDA margin is 31.05 percent (the operating margin is 20.72 percent and the net profit margin 16.83 percent).

Financial Analysis: The total debt represents 42.81 percent of Williams Partners's assets and the total debt in relation to the equity amounts to 94.98 percent. Due to the financial situation, a return on equity of 7.51 percent was realized by Williams Partners. Twelve trailing months earnings per share reached a value of $1.62. Last fiscal year, Williams Partners paid $3.20 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 32.38, the P/S ratio is 3.18 and the P/B ratio is finally 2.03. The dividend yield amounts to 6.51 percent and the beta ratio has a value of 1.00.

Altria Group (MO) has a market capitalization of $70.31 billion. The company employs 9,100 people, generates revenue of $24.618 billion and has a net income of $4.183 billion. Altria Group's earnings ! before interest, taxes, depreciation and amortization (EBITDA) amounts to $7.487 billion. The EBITDA margin is 30.41 percent (the operating margin is 25.91 percent and the net profit margin 16.99 percent).

Financial Analysis: The total debt represents 39.28 percent of Altria Group's assets and the total debt in relation to the equity amounts to 438.07 percent. Due to the financial situation, a return on equity of 121.70 percent was realized by Altria Group. Twelve trailing months earnings per share reached a value of $2.19. Last fiscal year, Altria Group paid $1.70 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 16.01, the P/S ratio is 2.87 and the P/B ratio is finally 22.36. The dividend yield amounts to 5.45 percent and the beta ratio has a value of 0.42.

National Grid (NGG) has a market capitalization of $43.97 billion. The company employs 25,224 people, generates revenue of $22.980 billion and has a net income of $3.674 billion. National Grid's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8.384 billion. The EBITDA margin is 36.49 percent (the operating margin is 26.62 percent and the net profit margin 15.99 percent).

Financial Analysis: The total debt represents 51.36 percent of National Grid's assets and the total debt in relation to the equity amounts to 274.69 percent. Due to the financial situation, a return on equity of 23.58 percent was realized by National Grid. Twelve trailing months earnings per share reached a value of $4.98. Last fiscal year, National Grid paid $3.27 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.03, the P/S ratio is 1.97 and the P/B ratio is finally 2.80. The dividend yield amounts to 5.23 percent and the beta ratio has a value of 0.61.

Top 10 Penny Companies For 2014!

!

Vodafone Group (VOD) has a market capitalization of $168.43 billion. The company employs 91,272 people, generates revenue of $71.130 billion and has a net income of $1.077 billion. Vodafone Group's earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $21.994 billion. The EBITDA margin is 30.92 percent (the operating margin is 10.64 percent and the net profit margin 1.51 percent).

Financial Analysis: The total debt represents 29.01 percent of Vodafone Group's assets and the total debt in relation to the equity amounts to 57.92 percent. Due to the financial situation, a return on equity of 0.58 percent was realized by Vodafone Group. Twelve trailing months earnings per share reached a value of $0.14. Last fiscal year, Vodafone Group paid $1.63 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 254.30, the P/S ratio is 2.28 and the P/B ratio is finally 1.44. The dividend yield amounts to 4.71 percent and the beta ratio has a value of 0.65.

Take a closer look at the full list of high yielding large capitalized stocks with buy ratings. The average P/E ratio amounts to 17.72 and forward P/E ratio is 14.01. The dividend yield has a value of 6.46 percent. Price to book ratio is 3.13 and price to sales ratio 1.63. The operating margin amounts to 17.39 percent and the beta ratio is 0.85. Stocks from the list have an average debt to equity ratio of 1.37.

Do you like this article? If yes, please support us and hit the button for a Facebook Like, make a tweet or post a comment in the Dividend Yield community! Thank you so much, we really appreciate it.

Related Stock Ticker Symbols:
VIP, ETP, CTL, NGG, WPZ, VIV, VOD, SDRL, MO, OKS, HMC, BP, E

Selected Articles:
· 17 High Yielding Dividend Achievers | Cheap Income Growth Stocks
· 16 High Yielding Dividend Stocks With Singe P/E Ratios
· 12 Stocks With Very High Yields And Positive Growth Expectations
· 17 High! Yields W! ith Additional Potential To Grow Dividends

*If you would like to receive more dividend stock ideas and the free Dividend Weekly, you should subscribe to my free e-mail list. Alternatively, you can follow me on Facebook or Twitter.

Stocks with high dividend yields and buy ratings originally published at long-term-investments.blogspot.com.

Wednesday, September 25, 2013

Doing the Unexpected Will Pay Off for Whole Foods

The organic foods business is a $60 billion global industry, and no other grocery chain has profited from this boom as much as Whole Foods Market Inc. (Nasdaq: WFM).

Whole Foods is leading the charge of supplying organic, natural, and locally grown foods to the health-conscious eater. Founded in 1980, it now has a count of 355 stores in 40 states and 3 countries.

WFM stock has shown astronomic growth as well, with shares up nearly 500% in five years.

The growth will continue. According to the U.S. Food and Drug Administration, organic food consumption has gone up 9% per year over the last five years. Future growth rates could be greater than 8% annually.

That's why competition is increasing. A slew of competitors are taking a page out of Whole Foods' book and expanding rapidly.

Can Whole Foods' industry dominance - and WFM's stock tear - continue?

Let's dig in and find out.

Whole Foods Clear Advantage

Whole Foods is doing something that may seem impossible - it is thriving in troubled economic times. Profits rose 20% in the most recently reported quarter, with earnings per share of 38 cents and revenue rising more than 12%.

Whole Foods sales of $11.7 billion in 2012 account for only 2% of the U.S. supermarket industry. To capitalize on this still-growing industry, Whole Foods has laid out plans to increase its store count to 1,000 over the long term.

One advantage Whole Foods has over the competition: the shopping experience. It's not one that other stores have duplicated.

Loyal Whole Foods patrons love the trained and educated personnel that range from experienced butchers, fishmongers, dietitians, and cheese connoisseurs to the sandwich makers and checkout clerks.

That's why same-store sales - although slightly slowing in the most recent quarter - have been increasing.

But other stores want to steal away the Whole Foods consumer...

WFM Stock Faces More Competition

Sprouts Farmers Market Inc. (Nasdaq: SFM) offers nearly the same type of products and produce as Whole Foods. It was rewarded handsomely by Wall Street with its extremely successful initial public offering (IPO) last month when it closed 120% up on its first day of trading.

Sprouts currently has 160 stores and looks to expand its number of stores by 12% annually, thanks to capital provided by the IPO.

The Fresh Market Inc. (Nasdaq: TFM), Natural Grocers by Vitamin Cottage Inc. (NYSE: NGVC), and privately held Trader Joe's are others crowding into the field.

In fact, even traditional grocery stores such as The Kroger Co. (NYSE: KR) are carving out large portions of their stores' floor spaces to accommodate the demand for organic and natural products.

But it's not just the growth rates that have lured grocers to the organic market...

They also enjoy higher profit margins than general grocery stores, which have to engage in price wars to attract customers.

Whole Foods, meanwhile, benefits from health-conscious consumers' willingness to pay more for healthy eating - which is why the store has the nickname "Whole Paycheck."

Whole Foods reported operating margins of 7.5% last quarter and expects them to be between 6.1% and 6.2% next quarter due to costs associated with store expansion. These types of numbers are the envy of many in the grocery business, but they are a direct result of charging higher prices for higher quality.

Lately, however, the chain has had to lower prices to compete. That's why Co-Chief Executive Officer (CEO) Walter Robb said "the perception is that Whole Foods is far more affordable than it was a few years ago."

These price reductions have not yet been reflected in WFM's profit margins. Investors should watch for when - and if - they are.

Something else WFM stock investors need to watch - a new demographic...

Whole Foods Breaks New Ground

In the past, this Whole Foods "lifestyle" was tailored to the affluent crowd who are not as price sensitive and can withstand the economic slowdown.

But that idea is changing - Whole Foods recently opened a store in the middle of bankrupt Detroit.

Many skeptics are wondering what Whole Foods is up to with this opening. But CEO Robb is committed to making a success of this venture. Keeping in mind his past successes, I am willing to give him the benefit of the doubt.

Robb has said that the Detroit store is "exceeding our wildest expectations."

Although the proof may not be in the "pudding" just yet, Whole Foods is committed to this new strategy, and it recently announced plans to open a new store in Englewood, IL - a poverty-stricken neighborhood in Chicago's south side.

If these stores succeed even modestly, this will give us a good indication that future stores in less-than-affluent areas will be equally successful, thus making the prospect of 1,000 more stores even more appetizing to investors.

What's Ahead for Whole Foods Stock

In addition to being in a good position to serve health-conscious consumers, the company has posted double-digit growth on both the top and bottom lines.

However, WFM stock's run has pushed its price to earnings (P/E) ratio into the upper 30s, and that introduces a note of caution into an otherwise positive outlook.

#symbols-c4ca4238a0b923820dcc509a6f75849b { width: 253px; font-family: Arial; font-size: 11px; color: #333333; } #symbols-c4ca4238a0b923820dcc509a6f75849b .header { float: left; font-family: Georgia; font-size: 14px; color: #456626; line-height: 14px; padding-left: 14px; font-weight: bold; } #symbols-c4ca4238a0b923820dcc509a6f75849b .date { float: right; padding-right: 32px; font-weight: bold; } #symbols-c4ca4238a0b923820dcc509a6f75849b .chart { font-family: Georgia; font-size: 12px; color: #456626; width: 253px; height: 135px; line-height: 135px; text-align: center; } #symbols-c4ca4238a0b923820dcc509a6f75849b ul { list-style: none; padding: 0; margin: 0; } #symbols-c4ca4238a0b923820dcc509a6f75849b li { padding: 0; margin: 0; } #symbols-c4ca4238a0b923820dcc509a6f75849b li:nth-child(odd) { background-color: #eeebe6; } #symbols-c4ca4238a0b923820dcc509a6f75849b .symbols-item .name { float: left; width: 100px; overflow: hidden; padding: 3px; } #symbols-c4ca4238a0b923820dcc509a6f75849b .symbols-item .price { float: left; width: 55px; overflow: hidden; padding: 3px; text-align: right; } #symbols-c4ca4238a0b923820dcc509a6f75849b .symbols-item .percent { float: left; width: 80px; overflow: hidden; padding: 3px; text-align: right; } #symbols-c4ca4238a0b923820dcc509a6f75849b .symbols-item.active { background-color: #456626; color: #ffffff; } #symbols-c4ca4238a0b923820dcc509a6f75849b .chart-container { width: 253px; height: 135px; padding: 0 0 5px 0; } #symbols-c4ca4238a0b923820dcc509a6f75849b .chart-container img { width: 253px; height: 135px; max-width: none; } .clear { clear: both; } Whole Foods Mkt NASDAQ: WFM Sep 24 loading chart... Price: 58.55 | Ch: 0.31 (0.5%)

Bottom line for Whole Foods (Nasdaq: WFM) stock: Although I am a buyer of Whole Foods stock, with economic conditions and the market at lofty levels, I would be wary of buying a full position at this time. A better approach may be to dollar-cost average into a position over the next few months.

Note: In yield-poor times like these, every investor should have at least a few dividend stocks in their portfolio. We've identified five dividend stocks that are stable and have particularly attractive yields...

Which stock do you want us to analyze? Send us a note in the comments section below and we'll add your pick to our list.

About the Author: David Mamos brings nearly 15 years of analytical experience to the table, with a background ranging from big-picture fundamental analysis to highly technical trading decisions. He began his career working as a financial advisor with Royal Alliance in 2001 and helped clients with portfolio management as well as buy-sell decisions before transitioning to the development, implementation, and execution of trading strategies for aggressive investors.

Related links:

Money Morning:
What to Do with Yahoo's (Nasdaq: YHOO) 80% Gain Money Morning:
Buy, Sell, or Hold: SAIC's Two-for-One Sale Financial Times:
Whole Foods Targets Low-Income Market in Chicago's Mean Streets

Monday, September 23, 2013

BlackBerry Leaves 4,500 Employees Out in the Cold

NEW YORK (TheStreet) -- BlackBerry's (BBRY) sudden and unexpected move on its consumer business makes the deal team at Microsoft (MSFT) appear brilliant for locking down the wireless assets of Nokia (NOK).

The real winner from the end of consumer BlackBerry phones appears to be Microsoft. Apple (AAPL) and Android phones already enjoy the majority of market share that cutting up BlackBerry's consumer segment won't amount to much. Let's take a look at BlackBerry and what investors can expect.

About a month ago I wrote my latest valuation assessment of BlackBerry to temper irrational exuberance. The article was in response to the shares soaring higher on news BlackBerry was looking for a buyer.

Here's the germane takeaway: "As an investor, I wouldn't try to get cute and hold out for everything you can. This is a buyer's market, and every participant knows it. A year ago, BlackBerry was still cash-flow positive and was months away from releasing BB10. That's a whole different landscape than BlackBerry currently finds itself navigating. "After adjusting the balance sheet from a bird's eye view, I think BlackBerry has scrap sale assets near $7.5 billion. Remove $3.6 billion in liabilities and you have a total value near $4 billion. "BlackBerry has 515 million shares, so you take $4 billion divided by 515 million shares, leaves you with $7.75 per share as a starting point. The right buyer may view BlackBerry as a company that can generate profits under his or her management, and that brings us to a buyout valuation above $14 a share." The numbers have changed. If you've been keeping score, about a year ago I placed the scrap value slightly higher than $12 a share and that was before announcing they started bleeding cash. After BlackBerry 10 missed the last holiday shopping season because of endless delays and excuses, and only seconds away from kicking off the busiest shopping season of the year, BlackBerry's CEO Thorsten Heins decides now is the time to pull the plug on smartphones? Shutting down consumers sales this time of year doesn't make sense me unless one of two scenarios exist. BlackBerry has found a buyer willing to take the rest of the company and it doesn't want the drain of consumer sales/shutting it down and the unpleasantries of laying off 4,500 workers.

Or...

Sales of handsets are so bleak and burning through cash at such an accelerating rate that management believes even the best selling season of the year will result in increasing losses. It's hard to imagine sales have imploded on a scale that renders the fourth quarter a loser, but either way all related assets should be valued at scrap value.

After removing non-cash losses from inventory charges, the operating losses should come in between $20 million to $30 million from $1.6 billion in revenue. At face value, that's a long way from not being able to sell phones at a profit during the fourth quarter, leaving the most likely scenario BlackBerry is nearing a "strategic alternative."

Samsung, LG and HTC certainly make the list of usual suspects for contenders, albeit politically one has to give the edge to Google (GOOG), Microsoft (MSFT) and maybe even a longshot Yahoo! (YHOO). At the rate Yahoo!'s CEO Marissa Mayer is buying companies, Yahoo! might just enter the fray if for no other reason than to force Google or Microsoft to pay up. How should investors price their shares? Last month I calculated the scrap value near $7.75 a share as the starting low point. If you remove $1 billion in valuation, you're left with about $5.81. We can't add as much blue sky as before because we're not including consumer lower cost smartphones, taking the buyout valuation to around$11.50. Investors may find the right buyer to pay more, but the days of a $30 buyout left before the BB10 hit the shelves. Investors should plan accordingly. At the time of publication the author had no position in any of the stocks mentioned. Follow @RobertWeinstein This article was written by an independent contributor, separate from TheStreet's regular news coverage.

Robert Weinstein is an active trader focusing on the psychological importance of risk mitigation, emotion and financial behavior of market participants. Robert co-founded the investing blog StockSaints, where he writes a journal about his trading activity and experiences. In addition to TheStreet, Robert also contributes to Real Money Pro, providing real-time trading ideas for stocks, options and futures.

Sunday, September 22, 2013

Glencore Xstrata's ADR Gets Extra Attention

NEW YORK (TheStreet) -- Almost every morning I start the day by reading articles on world business news. Very often there are glowing analysts' reports about profitable turnaround opportunities outside the U.S. Investing in U.S. stocks can be complicated enough without having to worry about opening a foreign trading account, currency exchange rates and trying to report trading profits and losses in foreign exchanges.

An easy way to overcome all that is to see whether the foreign company you like is traded on U.S. exchanges as an American depositary receipt or global depositary receipt. Most stock-exchange screeners cover these in their data bases. If not, you can find information on the Internet or some of the brokerages that deal in ADRs, like BNY Mellon, JPMorgan or Deutsche Bank.

� A company I'm interested in is Glencore Xstrata PLC (GLNCY), which is trading as an ADR here in the U.S. Glencore began in 1974 as Marc Rich & Co AG as a marketer of metal and oil products. Later, under the name Glencore, it added segments in agricultural and energy products. In May of 2013, it merged with Xstrata PLC to form Glencore Xstrata PLC, trading on the London Stock Exchange (GLEN), the Hong Kong Stock Exchange (805) and in the U.S. OTC as an ADR (GLNCY).

What information besides press releases and new articles can we find? Remember that some of the accounting practices in foreign jurisdictions render numbers that are not comparable to the financial numbers you are used to seeing in U.S. stocks. For that reason, I tend to look at these ADRs more in technical terms. Let's see what we have. First, how is the ADR performing against my U.S. benchmark, the Value Line Index. During the last two-and-a-half months, roughly 50 trading sessions, Glencore was up 27.29%, while the index was up only 6.41%: Fundamental Factors Using the Friday LSE closing price, company has a market cap of £44,995,820, so at an exchange rate of 1.58722, that would make it $71,418,265 USD. Revenue is around $220 billion and net income at about $1 billion. The forward-looking P/E is 23. The dividend yield is 2.95%, with a payout ratio of 39.39%. Last year's revenue growth was 16.54%. U.S. investor interest is reflected by Wall Street analysts having issued 1 strong buy, 1 buy and 2 hold recommendations.

Technical indicators and charts provided by Barchart:

The ADR has 80% technical buy signals coupled with a Trend Spotter buy signal. It is trading above its 20-, 50- and 100-day moving averages and hit eight new highs, for a gain of 11.99% in the last month. The Relative Strength Index is 70.60% and Barchart computes a technical support level at 10.78. The ADR recently traded at 11.74 with a 50-day moving average of 9.10.

You may not have all the information you are used to seeing in a U.S. stock, but you easily find the changes in price, revenue, earnings and the forward-looking P/E ratio. When Wall Street brokerage firms have published recommendations, that's a plus.

Personally, I find my best bet is to monitor the price against the moving averages and look for the turtle channels to tell me when there is market weakness. Right now, after reviewing the chart below, I wish I wasn't already fully invested or I'd be adding this to my portfolio: At the time of publication VanMeerten did not own shares in this ADR or the underlying stock. This article was written by an independent contributor, separate from TheStreet's regular news coverage.

Saturday, September 21, 2013

Top Oil Companies To Watch For 2014

The United Kingdom has decided to refrain from an attack on Syria, although the United States may go it alone (or perhaps with France.) Obama has agreed to pass the decision to Congress which will debate the matter no earlier than September 9. And in Congress, Obama could lose his chance to punish Syria for its use of gas which killed over 1,400 people, altogether. �A limited military action, if approved, � could blunt the use of these chemical weapons. However, it could add to the violence and instability in the entire region. Whether or not Syria�� government is affected, its economy is bound to worsen, probably faster than the turmoil so far has caused already.

From the standpoint of these economic consequences, Syria�� gross domestic product (GDP) and imports and exports will have no effect on the economy in the rest of the world. It is too small.

Top Oil Companies To Watch For 2014: Magnum Hunter Resources Corp (MHR)

Magnum Hunter Resources Corporation (Magnum Hunter), incorporated in June 1997, is an independent oil and gas company engaged in the exploration for and the exploitation, acquisition, development and production of crude oil, natural gas and natural gas liquids, primarily in the states of West Virginia, Ohio, Texas, Kentucky and North Dakota and in Saskatchewan, Canada. The Company is also engaged in midstream operations, including the gathering of natural gas through its ownership and operation of a gas gathering system in West Virginia and Ohio, named as its Eureka Hunter Pipeline System. The Company�� portfolio includes Marcellus/Utica Shales in West Virginia and Ohio, the Eagle Ford Shale in south Texas, and the Williston Basin/Bakken Shale in North Dakota and Saskatchewan, Canada. As of December 31, 2011, its proved reserves were 44.9 million barrels of oil equivalent and were approximately 48% oil. In August 2012, the Company closed on the acquisition of 1,885 net mineral acres located in Atascosa County, Texas. With this acquisition, the Company has approximately 7,278 gross acres and 5,212 net acres located in Atascosa County, Texas.

On May 3, 2011, it acquired NuLoch Resources Inc. In April 2011, Triad Hunter, its wholly owned subsidiary, acquired certain Marcellus Shale oil and gas properties located in Wetzel County, West Virginia. On April 13, 2011, it acquired NGAS Resources, Inc. In February 2012, Triad Hunter acquired leasehold mineral interests located primarily in Noble County, Ohio.

Eagle Ford Shale Properties

Eagle Ford Shale is located in Gonzales, Lavaca, Atascosa and Fayette Counties, Texas. The Eagle Ford Shale properties are held primarily by its wholly owned subsidiary, Eagle Ford Hunter, Inc. As of February 27, 2012, the Company�� Eagle Ford Shale properties included approximately 54,000 gross (24,000 net) acres primarily targeting the Eagle Ford Shale oil window, principally in Gonzales and Lavaca Counties, Texas. As of December 31! , 2011, proved reserves attributable to the Eagle Ford Shale properties were 5.4 million barrels of oil equivalent, of which 94% were oil and 24% were classified as proved developed producing, and 5.4 million barrels of oil equivalent. As of February 27, 2012, its Eagle Ford Shale properties included 18 gross (10 net) productive wells, of which it operated 14.

Williston Basin Properties

The Williston Basin is spread across North Dakota, Montana and parts of southern Canada. The basin produces oil and natural gas from a range of producing horizons, including the Madison, Bakken, Three Forks/Sanish and Red River formations. As of February 27, 2012, the Company�� Williston Basin properties included approximately 413,003 gross (122,561 net) acres. As of December 31, 2011, proved reserves attributable to the Williston Basin properties were 8.9 million barrels of oil equivalent, of which 94% were oil and 42% were classified as proved developed producing, and 8.8 million barrels of oil equivalent. As of February 27, 2012, the Williston Basin properties included approximately 288 gross (98.9 net) productive wells.

The Williston Hunter United States property acreage is located in Divide and Burke Counties, North Dakota, with its primary production from the Bakken Shale and Three Forks/Sanish formations. As of February 27, 2012, its Williston Hunter United States properties included approximately 36,355 net acres in the Williston Basin in North Dakota. As of February 27, 2012, the Williston Hunter United States properties included approximately 105 gross (9.5 net) productive wells. The Company�� Williston Hunter Canada property is located primarily in Enchant, near Vauxhall, Alberta, Canada, at Balsam near Grande Prairie, Alberta, Canada and at Tableland, near Estevan, Saskatchewan, Canada. As of February 27 2012, the Williston Hunter Canada properties included approximately 107,270 gross acres (79,693 net acres). At December 31, 2011, the Williston Hunter Canada prope! rties inc! luded approximately 65 gross productive wells. As of December 31, 2011, Williston Hunter Canada had 41,797 gross (32,944 net) acres of land that is prospective for Bakken and Three Forks/Sanish oil in the Tableland field. The Enchant property consists of 10,720 acres. As of December 31, 2011, 48 wells (44.1 net) were producing on this acreage. As of December 31, 2011, the Company owned approximately 43% average interest in 15 fields located in the Williston Basin in North Dakota consisting of 151 wells, and approximately 15,000 gross (6,450 net) acres.

Appalachian Basin Properties

The properties acquired in the NGAS acquisition are held by its wholly owned subsidiary, Magnum Hunter Production, Inc. As of February 27, 2012, its Appalachian Basin properties included a total of approximately 484,412 gross (412,323 net) acres, located primarily in the Marcellus Shale, Utica Shale and southern Appalachian Basin. At December 31, 2011, proved reserves attributable to its Appalachian Basin properties were 29.9 million barrels of oil equivalent, of which 27% were oil and 59% were classified as proved developed producing, and 30.2 million barrels of oil equivalent. As of February 27, 2012, the Appalachian Basin properties included approximately 3,112 gross (2,257 net) productive wells, of which we operated approximately 88%.

As of February 27, 2012, it had approximately 58,426 net acres in the Marcellus Shale area of West Virginia and Ohio. The Company�� Marcellus Shale property is located principally in Tyler, Pleasants, Doddridge, Wetzel and Lewis Counties, West Virginia and in Washington, Monroe and Noble Counties, Ohio. As of February 27, 2012, the Company operated 33 vertical Marcellus Shale wells and 16 horizontal Marcellus Shale wells. As of February 27, 2012, approximately 63% of its leases in the Marcellus Shale area were held by production.

Other Properties

The Company�� East Chalkley field is located in Cameron Parish, Louisiana.! The fiel! d consists of approximately 714 gross acres (443 net acres). This developmental project is an exploitation of bypassed oil reserves remaining in a natural gas field located at depths between 9,300 and 9,400 feet. As of February 27, 2012, the Company operated the East Chalkley field and owned an approximately 62% working interest and an approximately 42.7% net revenue interest in the field. Other properties of the Company are located in Nacogdoches, Colorado, Lavaca, Bee, Fayette and Wharton Counties, Texas and Desoto Parish, Louisiana. As of February 27, 2012, these properties consisted of an aggregate of approximately 7,050 gross (1,188 net) acres.

Top Oil Companies To Watch For 2014: Markwest Energy Partners LP (MWE)

MarkWest Energy Partners, L.P. (MarkWest Energy) is a master limited partnership engaged in the gathering, processing and transportation of natural gas; the transportation, fractionation, storage and marketing of natural gas liquids (NGLs), and the gathering and transportation of crude oil. It provides services in the midstream sector of the natural gas industry. The Company also provides processing and fractionation services to crude oil refineries in the Corpus Christi, Texas area through its Javelina gas processing and fractionation facility. As of December 31, 2011, the Company operated in four segments: Southwest, Northeast, Liberty and Gulf Coast. Effective December 31, 2011, the Company acquired the remaining 49% interest in MarkWest Liberty Midstream. On February 1, 2011, the Company acquired Langley processing plant.

Southwest Segment

The Company owns a system in East Texas that consists of natural gas gathering pipelines, centralized compressor stations, a natural gas processing facility and an NGL pipeline. The East Texas system is located in Panola, Harrison and Rusk Counties and services the Carthage Field. Producing formations in Panola County consist of the Cotton Valley, Pettit, Travis Peak and Haynesville formations. During the year ended December 31, 2011, approximately 77% of its natural gas volumes in the East Texas System result from contracts with six producers. The Company sells substantially all of the purchased and retained NGLs produced at its East Texas processing facility to Targa Resources Partners, L.P. (Targa) under a long-term contract. Such sales represent approximately 19.4% of its consolidated revenue in 2011.

The Company owns a natural gas gathering system in the Woodford Shale play in the Arkoma Basin of southeast Oklahoma. The liquids-rich natural gas gathered in the Woodford system is processed through Centrahoma Processing LLC (Centrahoma), its equity investment, or other third-party processors. In addition, it owns the Foss Lake! natural gas gathering system and the Western Oklahoma natural gas processing complex, all located in Roger Mills, Beckham, Custer and Ellis Counties of western Oklahoma. The gathering portion consists of a pipeline system that is connected to natural gas wells and associated compression facilities. The Company also owns a gathering system in the Granite Wash formation in Wheeler County in the Texas panhandle that is connected to its Western Oklahoma processing complex. The Company completed the expansion of the Western Oklahoma natural gas processing plant in October 2011.

Approximately 70% of its Oklahoma volumes result from contracts with three producers in 2011. The Company sells substantially all of the NGLs produced in the Western Oklahoma processing complex to ONEOK Hydrocarbon L.P. (ONEOK) under a long-term contract. Such sales represent approximately 13.2% of its consolidated revenue in 2011. The Company owns a number of natural gas gathering systems located in Texas, Louisiana, Mississippi and New Mexico, including the Appleby gathering system in Nacogdoches County, Texas. It gathers a portion of the gas produced from fields adjacent to its gathering systems, including from wells targeting the Haynesville Shale. In addition, it owns four lateral pipelines in Texas and New Mexico.

Northeast Segment

The Company�� Northeast segment assets include the Kenova, Boldman, Cobb, Kermit and Langley natural gas processing plants, an NGL pipeline and the Siloam NGL fractionation plant. In addition, it has two caverns for storing propane at its Siloam facility and additional propane storage capacity under a long-term firm-capacity agreement with a third party. The Northeast segment operations include fractionation and marketing services on behalf of the Liberty segment. The Company owns and operates a crude oil pipeline in Michigan (Michigan Crude Pipeline) providing transportation service for three shippers.

Liberty Segment

The Company pr! ovides na! tural gas midstream services in southwestern Pennsylvania and northern West Virginia through MarkWest Liberty Midstream. It is a processor of natural gas in the Marcellus Shale, with gathering, processing, fractionation, storage and marketing operations.

Utica Segment

Effective January 1, 2012, the Company and The Energy and Minerals Group (EMG) formed MarkWest Utica EMG, a joint venture focused on the development of natural gas processing and NGL fractionation, transportation and marketing infrastructure to serve producers' drilling programs in the Utica shale in eastern Ohio. During 2011, the Utica Segment did not have any operations.

Gulf Coast Segment

The Company owns and operates the Javelina processing facility, a natural gas processing facility in Corpus Christi, Texas that treats and processes off-gas from six local refineries operated by three different refinery customers. As of December 31, 2011, the Company owned a 40% interest in Centrahoma Processing LLC (Centrahoma), a joint venture with Cardinal Midstream, LLC (Cardinal). Centrahoma owns certain processing plants in the Arkoma Basin and Cardinal operates an additional processing plant that is not owned by Centrahoma but is located adjacent to and operates in conjunction with the Centrahoma plants.

Top 10 High Tech Stocks To Watch For 2014: Pengrowth Energy Corp (PGH)

Pengrowth Energy Corporation (Pengrowth) is engaged in the development, production and acquisition of, and the exploration for, oil and natural gas reserves in the provinces of Alberta, British Columbia, Saskatchewan, Ontario and Nova Scotia. The Company�� producing properties include Lindbergh, Swan Hills Area, Greater Olds/Garrington Area and Southeast Saskatchewan. In February 2012, the Company commenced the injection of steam at its Lindbergh pilot project. On May 31, 2012, the Company acquired NAL Energy Corporation. In November 2012, the Company acquired additional Lochend Cardium assets with production capability of approximately 650 barrels of oil equivalent, weighted 95% to light oil. In March 2013, the Company completed the divestiture of its non-core Weyburn asset.

Top Oil Companies To Watch For 2014: Linn Energy LLC (LINE)

Linn Energy, LLC (LINN Energy) is an independent oil and natural gas company. The Company�� properties are located in the United States, primarily in the Mid-Continent, the Permian Basin, Michigan, California and the Williston Basin. Mid-Continent Deep includes the Texas Panhandle Deep Granite Wash formation and deep formations in Oklahoma and Kansas. Mid-Continent Shallow includes the Texas Panhandle Brown Dolomite formation and shallow formations in Oklahoma, Louisiana and Illinois. Permian Basin includes areas in West Texas and Southeast New Mexico. Michigan includes the Antrim Shale formation in the northern part of the state. California includes the Brea Olinda Field of the Los Angeles Basin. Williston Basin includes the Bakken formation in North Dakota. On December 15, 2011, the Company acquired certain oil and natural gas properties located primarily in the Granite Wash of Texas and Oklahoma from Plains Exploration & Production Company (Plains).

On November 1, 2011, and November 18, 2011, it completed two acquisitions of certain oil and natural gas properties located in the Permian Basin. On June 1, 2011, it acquired certain oil and natural gas properties in the Cleveland play, located in the Texas Panhandle, from Panther Energy Company, LLC and Red Willow Mid-Continent, LLC (collectively Panther). On May 2, 2011, and May 11, 2011, it completed two acquisitions of certain oil and natural gas properties located in the Williston Basin. On April 1, 2011, and April 5, 2011, the Company completed two acquisitions of certain oil and natural gas properties located in the Permian Basin. On March 31, 2011, it acquired certain oil and natural gas properties located in the Williston Basin from an affiliate of Concho Resources Inc. (Concho). During the year ended December 31, 2011, the Company completed other smaller acquisitions of oil and natural gas properties located in its various operating regions. As of December 31, 2011, the Company operated 7,759 or 69% of its 11,230 gross productiv! e wells.

Mid-Continent Deep

The Mid-Continent Deep region includes properties in the Deep Granite Wash formation in the Texas Panhandle, which produces at depths ranging from 10,000 feet to 16,000 feet, as well as properties in Oklahoma and Kansas, which produce at depths of more than 8,000 feet. Mid-Continent Deep proved reserves represented approximately 47% of total proved reserves, as of December 31, 2011, of which 49% were classified as proved developed reserves. The Company owns and operates a network of natural gas gathering systems consisting of approximately 285 miles of pipeline and associated compression and metering facilities that connect to numerous sales outlets in the Texas Panhandle.

Mid-Continent Shallow

The Mid-Continent Shallow region includes properties producing from the Brown Dolomite formation in the Texas Panhandle, which produces at depths of approximately 3,200 feet, as well as properties in Oklahoma, Louisiana and Illinois, which produce at depths of less than 8,000 feet. Mid-Continent Shallow proved reserves represented approximately 20% of total proved reserves, as of December 31, 2011, of which 70% were classified as proved developed reserves. The Company owns and operates a network of natural gas gathering systems consisting of approximately 665 miles of pipeline and associated compression and metering facilities that connect to numerous sales outlets in the Texas Panhandle.

Permian Basin

The Permian Basin is an oil and natural gas basins in the United States. The Company�� properties are located in West Texas and Southeast New Mexico and produce at depths ranging from 2,000 feet to 12,000 feet. Permian Basin proved reserves represented approximately 16% of total proved reserves, as of December 31, 2011, of which 56% were classified as proved developed reserves.

Michigan

The Michigan region includes properties producing from the Antrim Shale formation in the northern ! part of t! he state, which produces at depths ranging from 600 feet to 2,200 feet. Michigan proved reserves represented approximately 9% of total proved reserves, as of December 31, 2011, of which 90% were classified as proved developed reserves.

California

The California region consists of the Brea Olinda Field of the Los Angeles Basin. California proved reserves represented approximately 6% of total proved reserves, as of December 31, 2011, of which 93% were classified as proved developed reserves.

Williston Basin

The Williston Basin is one of the premier oil basins in the United States. The Company�� properties are located in North Dakota and produce at depths ranging from 9,000 feet to 12,000 feet. Williston Basin proved reserves represented approximately 2% of total proved reserves, as of December 31, 2011, of which 48% were classified as proved developed reserves.

Top Oil Companies To Watch For 2014: HRT Participacoes em Petroleo SA (HRTPY.PK)

HRT Participacoes em Petroleo SA, formerly BN 16 Participacoes Ltda, is a Brazil-based holding company engaged in the oil and gas industry. The Company is primarily involved in the exploration and production (E&P) of oil and natural gas in Brazil and Namibia. Through its subsidiaries, it is active in the geophysical and geological research, exploration, development, production, import, export and sale of oil and natural gas, as well as in the provision of air logistics services in transporting people and equipment related to oil and gas activities in the exploratory campaign in the Solimoes Basin. As of December 31, 2011, the Company had seven subsidiaries, including Integrated Petroleum Expertise Company Servicos em Petroleo Ltda (IPEX), HRT O&G Exploracao e Producao de Petroleo Ltda, HRT Netherlands BV, HRT America Inc, HRT Africa, HRT Canada Inc and Air Amazonia Servicos Aereos Ltda.

Top Oil Companies To Watch For 2014: Worthington Energy Inc (WGAS.PK)

Worthington Energy, Inc. (Worthington), formerly Paxton Energy, Inc., incorporated July 30, 2004, is an oil and gas exploration and production company with assets in Texas and in the Gulf of Mexico. Worthington�� assets in Texas consist of a minority working interest in limited production and drilling prospects in the Cooke Ranch area of La Salle County, Texas, and Jefferson County, Texas, all operated by Bayshore Exploration L.L.C. (Bayshore). The Company�� assets in the Gulf of Mexico consist of a leasehold working interests in certain oil and gas leases located offshore from Louisiana, upon which no drilling or production has commenced as of December 31, 2011, and a 10.35% interest in the recently drilled I-1 well and a 2% royalty interest in 14,400 acres in the Mustang Island Tract 818. On March 27, 2012, it acquired certain assets from Black Cat Exploration & Production, LLC.

In Texas, the Company has working interests ranging from 4% to 31.75% (ne t revenue interests ranging from 3% to 23.8125%) in the various wells. In the Gulf of Mexico it has a 70% leasehold working interest, with a net revenue interest of 51.975%, of certain oil and gas leases in the Vermillion 179 tract and 10.35% interest in the recently drilled I-1 well and a 2% royalty interest in 14,400 acres in the Mustang Island Tract 818. As of December 31, 2011, it had one producing well that generated average total monthly net revenue.

The Mustang Island 818-L Field, located in the Kleberg County waters of the Gulf of Mexico, is a field re-habilitation project targeting bypassed or only partially produced gas-condensate. Total production from the wells within the seismic coverage was 125.6 billion cubic feet. In January 2011, the Hercules Offshore 205 jack-up rig was contracted to re-enter the I-Well on the Mustang License Area. The oil and gas leases are located in the VM 179, which is in the shallow waters of the Gulf of Mexico offshore fr om Louisiana. VM 179 is at 85 inches water depth approxima! te! ly 46 miles offshore Louisiana in the Gulf of Mexico.

Top Oil Companies To Watch For 2014: New Concept Energy Inc (GBR)

New Concept Energy, Inc. (New Concept), incorporated on May 30, 1991 in, owns and operates oil and gas wells in Ohio and West Virginia. The Company, through its wholly owned subsidiaries Mountaineer State Energy, Inc. and Mountaineer State Operations, LLC. operates oil and gas wells and mineral leases in Athens and Meigs Counties in Ohio and in Calhoun, Jackson and Roane Counties in West Virginia. As of March 30, 2012, the Company had 159 producing gas wells, 27 non-producing wells and related equipment and mineral leases covering approximately 20,000 acres. The Company operates in two primary business segments: oil and gas operations and retirement facilities.

During the year ended December 31, 2011, the Company had drilled eight wells. New Concept focuses on North American onshore oil and natural gas drilling and exploration. The Company's properties are concentrated in the Appalachian Basin, Fort Worth Basin, and the Arkoma Basin. The Company leases and operates Pacific Pointe Retirement Inn (Pacific Pointe) in King City, Oregon. Pacific Pointe has a capacity of 114 residents and provides community living with basic services, such as meals, housekeeping, laundry, 24/7 staffing, transportation and social and recreational activities.

Top Oil Companies To Watch For 2014: Southern Union Company(SUG)

Southern Union Company, together with its subsidiaries, engages in the gathering, processing, transportation, storage, and distribution of natural gas in the United States. It operates in three segments: Transportation and Storage, Gathering and Processing, and Distribution. The Transportation and Storage segment engages in the interstate transportation and storage of natural gas in the Midwest and from the Gulf Coast to Florida. It also provides liquefied natural gas (LNG) terminalling and regasification services. The Gathering and Processing segment involves in gathering, treating, processing, and redelivering natural gas and natural gas liquids (NGLs) in Texas and New Mexico. It operates a network of approximately 5,500 miles of natural gas and NGL pipelines, 4 cryogenic processing plants with a combined capacity of 415 MMcf/d, and 5 natural gas treating plants with a combined capacity of 585 MMcf/d. The Distribution segment engages in the local distribution of natural gas in Missouri and Massachusetts. This segment serves residential, commercial, and industrial customers through local distribution systems. The company was founded in 1932 and is based in Houston, Texas.

Friday, September 20, 2013

Weekend Edition – The Perils of Chasing Yield

Income investors, for the most part, look for investments with attractive, and sometimes large, yields. Whether it is with dividend stocks, bonds, or some other sort of asset class, income investors want a good return on their investments, and they will search high and low to find these yields. However, at certain times it can be difficult to find attractive, low risk yields, especially when the central banks in developed countries lower interest rates. In a low interest rate environments like this, income investors will break from their normally risk-averse nature and seek out higher-yield investments in risky assets. While this speculative strategy might work for a short while, it can come back to bite investors if they are not careful. As recent developments in emerging financial markets show, there can be unnecessary perils to this sort of yield chasing strategy.

How Did This Era of Yield Chasing Arise?

Following the bursting of the housing bubble, the financial crisis, and the Great Recession, the Federal Reserve lowered the federal funds rate to near zero, which was a monetary policy tool intended to lower short-term interest rates to stimulate the economy. Furthermore, the Fed eventually started buying up mortgage-backed securities and U.S. Treasuries in an attempt to lower long-term interest rates. By doing so, the Fed had effectively lowered the interest rates on all sorts of financial assets in the United States, like savings accounts, CDs, bonds, etc., posing a difficult challenge to investors and savers who desired attractive rates and yields in their investments. As such, all kinds of investors, both individual and institutional, started chasing yields in various investment vehicles. REITs, MLPs, BDCs, junk bonds, and high-yielding ETFs became sought after by investors, despite some of the risks tied to these assets. But investors didn’t stop there: higher yield investments in emerging stock, bond, and currency markets became an attractive area to put money.

Emerging Markets Take a Hit

While the move worked out well initially, over the past couple months the stock, bond, and currency markets in developing economies like India and Indonesia have been taking a beating. As interest rates started to rise in developed economies like the United States and the United Kingdom due to tighter monetary policies, the investors mentioned above started to pull money from the emerging markets to invest it in less risky assets in more established economies. This bit of rotation has caused the value in the stock, bond, and currency markets of these various countries to plummet. While some investors got out in the nick of time, many passive investors could have been behind the curve causing their holdings to drop in value. In the end, the yield chasing might not have been worth all of the risk and speculation for us retail investors.

Leave the Speculation to the Professionals

This strategy of chasing yield across a variety of asset classes as the financial economic landscape changes may work out for active investors, but it is not easy. As the example of the emerging market situation above shows, only those investors who were on top of the ever-changing developments came out as winners. Typically, these are the professional and institutional investors who do it for a living.

Top 10 Undervalued Companies To Invest In 2014

For us retail income investors who employ a traditional passive, buy and hold strategy, seeking out high yields in all sorts of asset classes can be a difficult, frustrating, and ultimately losing proposition. Instead, we should stick to that buy and hold strategy of well established dividend paying stocks. Leave the speculation and the active investing to the professionals.

High Yields Can Be Misleading

This all goes to show you that yield isn’t everything when it comes to investments. While it is without a doubt nice to see income from our investments month after month, quarter after quarter, if this income isn’t sustainable, is it worth it? With regards to the emerging markets example above, it was more-or-less the decline of the principal that burned investors. With many high-yield assets, the yields themselves are unsustainable due to a number of factors, like unforeseen quarter-to-quarter fluctuations in earnings. Because of these potential downside risks, investing in high-yield assets might not lead to the gains that one might initially think.

Sunday, September 15, 2013

Oasis Petroleum: Analysts See Big Upside For This Bakken Producer

Regular readers of these columns know that I am a big bull on a good number of E&P concerns on the back of the huge domestic oil & gas production surge within the United States over the last 6-8 years. I own and have written extensively about a variety of smaller plays among these producers over the last two years. Bakken producer Oasis Petroleum (OAS) is a stock I have owned and written about since April of last year.

Oasis is up better than 40% over that time frame to better than $43 a share. However, I still believe this fast growing producer has further upside. The company just made a significant purchase and has had received some very positive actions from analysts. It seems an appropriate time to revisit its investment thesis.

Recent Positives:

The company just acquired over 160,000 of additional acres in the Bakken for $1.5B. This ease concerns that Oasis would start to explore outside its core competency area of the Bakken and should give it some economies of scale. The company will now be producing ~43,000 BOE/D (Barrels of Oil Equivalent/Day) on almost 500,000 acres.Oil prices approaching $110/Barrel on WTI is certainly positive for all domestic energy producers.Deutsche Bank upgraded the shares to a "Buy" after the acquisition and raised its price target to $55 a share from $45.RBC Capital raises its price target to $64 a share and moves the stock to "Outperform".Suntrust states shares have more than 25% upside after purchase.Raymond James called Oasis one of its top energy picks a month prior to this acquisition.Finally, Jefferies tops all of them raising the price target to $68 a share and stating bull case calls for $80 price target.

Top 10 Low Price Companies To Watch In Right Now

Valuation:

The company was already tracking to better than 55% revenue growth this year prior to this latest acquisition. Analysts had penciled in over 25% sales i! ncreases in 2014 as well. Look for these estimates to be taken up substantially over the next few weeks as this new production is factored into the equation. The stock sports a tiny five year projected PEG (.50) indicative that the market may not accounting properly for its substantial growth drivers.

The stock is not expensive given its growth rate, selling for 12.5x next year's projected EPS (and look for this estimate to be revised up nicely by end of month as purchase is put into equation). The company has increased operating cash flow by more than 800% since the end of FY2010 and the stock sells at just ~7x trailing annual operating cash flow. BUY.

Source: Oasis Petroleum: Analysts See Big Upside For This Bakken Producer

Disclosure: I am long OAS. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)

Saturday, September 14, 2013

10 Best Biotech Stocks To Buy For 2014

With the�SPDR S&P Biotech Index�up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies that made waves in the sector last week.

If the biotech sector was to make a movie, I'd have suggested the title be "The Good, the Bad, and the Intriguing" following this week's action.

The good
Leading to the plus column was biotech cancer drug developer Onyx Pharmaceuticals (NASDAQ: ONXX  ) which soared 57% on the week (nearly $50 a share!) after receiving a buyout bid from Amgen�for what amounted to $120 a share. Onyx quickly rebuffed the offer price as too low but did note it was actively looking for strategic alternatives that would properly value Onyx and its pipeline. Earlier in the week I took a deeper dive into Onyx and pegged its fair value at $145 a share. Although I favor the potential of its pipeline, I'm starting to see little upside left in shares at these levels.

10 Best Biotech Stocks To Buy For 2014: Organovo Holdings Inc (ONVO.PK)

Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., incorporated in 2007, is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. On December 28, 2011, Real Estate Restoration and Rental, Inc.�� (RERR) entered into an Agreement and Plan of Merger, pursuant to which RERR merged with its, wholly owned subsidiary, Organovo (Merger Sub). On February 8, 2012, the Company merged with and into Organovo Acquisition Corp. (Acquisition Corp.), a wholly owned subsidiary of Organovo, with the Company surviving the merger as a wholly owned subsidiary of Organovo Holdings (the Merger). As a result of the Merger, Organovo acquired the business of Organovo, Inc.

The C ompany has collaborative research agreements with Pfizer, Inc. (Pfizer) and United Therapeutic Corporation (Unither). As of March 31, 2012, it has five federal grants, including Small Business Innovation Research grants and developed the NovoGen MMX Bioprinter (its first-generation 3D bioprinter). The Company is engaged in the development of specific 3D human tissues to aid Pfizer in discovery of therapies in two areas of interest. In addition, in October 2011, it entered into a research agreement with Unither to establish and conduct a research program to discover treatments for pulmonary hypertension using its NovoGen MMX Bioprinter technology. Additionally, under the research agreement with Unither, the Company granted Unither an option to acquire from the Company a worldwide, royalty-bearing license in certain intellectual property created under the research agreement solely for use in the treatment or prevention of pulmonary hypertension and all other lung diseases.

The Company�� NovoGen MMX Bioprinter is an aut! om! ated device that enables the fabrication of three-dimensional (3D) living tissues comprised of mammalian cells. A custom graphic user interface (GUI) facilitates the 3D design and execution of scripts that direct precision movement of the dispensing heads to deposit cellular building blocks (bio-ink) or supporting hydrogel. The Company is using a third party manufacturer, Invetech Pty., of Melbourne, Australia, to manufacture its NovoGen MMX Bioprinter. Its bioprinting technology and surrounding intellectual property and commercial rights serve as a platform for product generation across multiple markets that employ cell- and tissue-based products and services.

The Company competes with Organogenesis, Advanced BioHealing, Tengion, Genzyme, HumaCyte and Cytograft Tissue Engineering.

10 Best Biotech Stocks To Buy For 2014: EntreMed Inc (ENMD.PH)

EntreMed, Inc. (EntreMed), incorporated in 1991, is a clinical-stage pharmaceutical company. EntreMed's drug candidate is ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer. ENMD-2076 has completed Phase I studies in patients with advanced solid tumors, multiple myeloma and leukemia and is completing data for a multi-center Phase II study in patients with platinum resistant ovarian cancer. The Company�� other product candidates have includes MKC-1, ENMD-1198 and 2-methoxyestrdiol (2ME2, Panzem) for treatment of rheumatoid arthritis.

ENMD-2076 is a novel orally-active, Aurora A/angiogenic kinase inhibitor with potent activity against Aurora A and multiple tyrosine kinases linked to cancer and inflammatory diseases. ENMD-2076 is relatively selective for the Aurora A isoform in comparison to Aurora B. Aurora kinases are key regulators of the process of mitosis, or cell division, and are often over-expressed in human cancers. E NMD-2076 exerts its effects through multiple mechanisms of action, including anti-proliferative activity and the inhibition of angiogenesis. ENMD-2076 has demonstrated significant, dose-dependent preclinical activity as a single agent, including tumor regression, in multiple xenograft models (such as breast, colon, leukemia), as well as activity towards ex vivo-treated human leukemia patient cells.

Top 10 Blue Chip Stocks To Own Right Now: Navidea Biopharmaceuticals Inc (NAVB)

Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, incorporated in 1983, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company�� radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of Technetium Tc99m for Injection), a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent, and RIGScan, a tumor antigen-specific targeting agent. In January 2012, the Company executed an option agreement with Alseres Pharmaceuticals, Inc. (Alseres) to license [123I]-E-IACFT Injection, also called Altropane, an Iodine-123 radiolabeled imaging agent, being developed as an aid in the diagnosis of Parkinson�� disease, movement disorders and dementia. In August 2011, the Company sold its gamma detection device line of business (the GDS Business) to Devicor Medical Products, Inc.

Lymphoseek

Navidea�� pipeline includes clinical-stage radiopharmaceutical agents used to identify the presence and status of disease. Lymphoseek (Kit for the Preparation of Technetium Tc99m for Injection) is a lymph node targeting agent intended for use in intraoperative lymphatic mapping (ILM) procedures and lymphoscintigraphy employed in the overall diagnostic assessment of certain solid tumor cancers. The lymph system is a component of the body�� immune system. The key components of the lymph system are lymph nodes-small anatomic structures that contain disease-fighting lymphocytes, filter lymph of bacteria and cancer cells, and signal infection in response to heightened levels of pathogens. In Navidea�� Phase III clinical studies of Lymphoseek, it detected over 99% of positive nodes identified by vital blue dye (VBD). As of December 31, 2011, Navidea, in co-operation with UC, San Diego affiliate (UCSD), completed or initiated five Phase I clinical trials, one multi-center Phase II trial and three multi-center Phase II trials inv! olving Lymphoseek. Two Phase III studies were completed in subjects with breast cancer and melanoma. During the year ended December 31, 2011, data from NEO3-09 were released, which indicated that all primary and secondary endpoints for the study were met. As of December 31, 2011, third Phase III clinical trial for Lymphoseek in subjects with head and neck squamous cell carcinoma (NEO3-06) was in progress.

AZD4694

AZD4694 is a Fluorine-18 labeled precision radiopharmaceutical candidate for use in the imaging and evaluation of patients with signs or symptoms of cognitive impairment such as Alzheimer's disease (AD). It binds to beta-amyloid deposits in the brain that can then be imaged in positron emission tomography (PET) scans. Amyloid plaque pathology is a required feature of AD and the presence of amyloid pathology is a supportive feature for diagnosis of probable AD. Patients who are negative for amyloid pathology do not have AD. AZD4694 has been studied in several clinical trials. Clinical studies through Phase IIa have included more than 80 patients to date, both suspected AD patients and healthy volunteers. No significant adverse events have been observed. Results suggest that AZD4694 has the ability to image patients quickly and safely with high sensitivity.

RadioImmunoGuided Surgery

As of December 31, 2011, RIGScan had been studied in a number of clinical trials, including Phase III studies. Navidea has conducted two Phase III studies, NEO2-13 and NEO2-14, of RIGScan in patients with primary and metastatic colorectal cancer, respectively. Both studies were multi-institutional involving cancer treatment institutions in the United States, Israel, and the European Union.

The Company competes with Pharmalucence, Eli Lilly, Bayer Schering, General Electric and GE Healthcare.

10 Best Biotech Stocks To Buy For 2014: Exelixis Inc.(EXEL)

Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer. It focuses on developing Cabozantinib, an inhibitor of tumor growth, metastasis, and angiogenesis that target MET, VEGFR2, and RET, which are key kinases involved in the development and progression of various cancers. The cabozantinib is in Phase III clinical trial for the treatment for medullary thyroid cancer. The company also engages in various clinical programs for cabozantinib focused on the treatment of metastatic castration-resistant prostate cancer, ovarian cancer, breast cancer, renal cell carcinoma, non-small cell lung cancer, hepatocellular cancer, and melanoma. In addition, Exelixis, Inc. involves in developing a portfolio of other novel compounds to address serious unmet medical needs through collaborations with various pharmaceutical and biotechnology companies, including Bristol-Myers Squibb Company, sanofi-aventis, Genentech, Inc., Boehringer Ingelheim Gm bH, and GlaxoSmithKline and Daiichi Sankyo Company Limited. Its products under development through collaborations include XL475, XL281, XL139, and XL413 inhibitors; ROR antagonists; therapies targeted against LXR, a nuclear hormone receptor implicated in various cardiovascular and metabolic disorders; XL147, XL765, and isoform-selective PI3K inhibitors; XL518, a small-molecule inhibitor of MEK; sphingosine-1-phosphate type 1 receptor; XL880 inhibitor; and therapies targeted against the mineralocorticoid receptor, a nuclear hormone receptor implicated in various cardiovascular and metabolic diseases. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California.

Advisors' Opinion:
  • [By Stephen]

    This drug-development company will go before the FDA later this year and throughout 2012 and 2013 with a series of new drug applications. Exelixis' drug cabozantinib, code-named XL1-84, has shown a great deal of promise with a range of metastasizing tumors. The drug is being tested in the treatment of several types of cancers, hence the multiple filings with the federal regulator.

    But a much closer catalyst exists: at the annual American Society of Clinical Oncology meeting, to be held in early June, Elexilis will present data from the phase II trial of cabozantinib. If history is any guide, then the interim testing results will be well-received by shareholders.

    During the second half of 2011, the drug will go deeper into the clinical testing trials. Each time that happens, the company will provide effectiveness data on the performance of the prior round of testing. Results from a phase III study of metastasized thyroid cancers are expected to be concluded in a few months, while phase III studies for the treatment of prostate cancer are expected to begin later this year. Every one of these instances could be a catalyst to take shares higher.

    As a final catalyst, Exelixis has allegedly been having discussions with potential buyers, according to Bloomberg, though waiting on such a transaction before making a move also represents risk. Investors bid up shares of Savient Pharma (Nasdaq: SVNT) after the company put itself up for sale. Hopes for a quick profit were dashed when the company couldn't find any suitors and shares lost almost half of their value in just one day.

10 Best Biotech Stocks To Buy For 2014: Prima BioMed Ltd (PBMD)

Prima BioMed Ltd is a biotechnology company is engaged in the development and commercialization of medical therapies with a focus on oncology. Its product candidates in development include Cvac, an autologous dendritic cell vaccine for ovarian cancer, monoclonal antibodies for multiple tumour types, and an oral formulation for the human papilloma virus (HPV), vaccine. Its product candidate Cvac is a dendritic cell therapy, for which it is conducting a Phase IIb trial for the treatment of ovarian cancer. Cvac is designed to target the tumour antigen mucin-1, which is expressed at high levels on different tumour types. It also has two preclinical product development programs. In May 2011, Prima BioMed GmbH, a 100 % owned subsidiary of Prima BioMed Ltd, was incorporated in Germany. In May 2011, Prima BioMed Middle East FZLLC, a 100 % owned subsidiary of Prima BioMed Ltd, was incorporated in the United Arab Emirates.

10 Best Biotech Stocks To Buy For 2014: Savient Pharmaceuticals Inc(SVNT)

Savient Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing KRYSTEXXA, a biologic PEGylated uricase in the United States. The KRYSTEXXA is being developed as a treatment for chronic gout in patients refractory to conventional therapy. The company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. It sells its products directly to drug wholesalers. The company, formerly known as Bio-Technology General Corp. and changed its name to Savient Pharmaceuticals, Inc. in June 2003. Savient Pharmaceuticals, Inc. was founded in 1980 and is headquartered in East Brunswick, New Jersey.

10 Best Biotech Stocks To Buy For 2014: Celsion Corporation(CLSN)

Celsion Corporation, an oncology drug development company, develops and commercializes targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company is developing its lead product, ThermoDox that is in Phase III clinical trial for primary liver cancer; and in phase II clinical trial for treatment of recurrent chest wall breast cancer. It has a license agreement with Yakult Honsha to commercialize and market ThermoDox for the Japanese market. The company also has a license agreement with Duke University under which it received exclusive rights to commercialize and use Duke's thermo-liposome technology. In addition, Celsion Corporation has a joint research agreement with Royal Phillips Electronics to evaluate the combination of Phillips' high intensity focused ultrasound with its ThermoDox to determine the potential of this combination to treat a range of cancers. The company was founded in 1982 and is based in Columbia, M aryland.

Advisors' Opinion:
  • [By Putnam]

    This is another play on clinical trial progress as a catalyst for higher share prices. This micro-cap stock uses heat-sensitive nano-particles to precisely place cancer-treatment drugs within specific tumors. A number of approaches are currently being tested. The first approach uses its ThermoDox technology in conjunction with radio frequency (RF) ablation for primary liver cancer. ThermoDox is being evaluated under a special protocol assessment with the FDA in a pivotal 600-patient Phase III trial. Results from this study are expected to be released in the next few months.

    Celsion shares weakened in the first quarter, as the company has sold new stock on a pair of occasions to keep the balance sheet healthy. Further equity offerings appear likely, but with positive feedback from the FDA, shares could pop nicely higher before that happens.

10 Best Biotech Stocks To Buy For 2014: OncoGenex Pharmaceuticals Inc.(OGXI)

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. The company?s clinical stage products include Custirsen, a phase III clinical stage product for treatment in men with metastatic castrate-resistant prostate cancer; OGX-427, which is in phase II clinical development stage is designed to inhibit heat shock protein 27; and SN2310 that completed phase I stage of clinical development is designed to evaluate safety in patients with advanced cancer. Its pre clinical stage products include GX-225 that is focused on reducing the production of IGFBP-2 and IGFBP-5; and CSP-9222, lead compound from a family of caspase activators. OncoGenex Pharmaceuticals, Inc. is based in Bothell, Washington.

10 Best Biotech Stocks To Buy For 2014: Dendreon Corporation(DNDN)

Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. The company offers active cellular immunotherapy and small molecule product candidates to treat various cancers. Its product candidates comprise Provenge (sipuleucel-T), an active cellular immunotherapy for the treatment of metastatic, castrate-resistant prostate cancer; DN24-02, an investigational active immunotherapy for the treatment of patients with bladder, breast, ovarian, and other solid tumors expressing HER2/neu; and TRPM8, a small molecule agonist to transient receptor potential ion channel, for multiple cancers. The company also has a range of products in preclinical studies, which include Carcinoembryonic antigen for the treatment of lung, colon, and breast cancer; and Carbonic AnhydraseIX for the treatment of kidney cancer. Dendreon Corporation was founded in 1992 and is headquartered in S eattle, Washington.

Advisors' Opinion:
  • [By Dan Moskowitz]

    Dendreon is suffering from lower product sales, which is due to increased competition. Costs are too high, and the company culture is awful. On the other hand, Dendreon narrowed its loss in Q1 on a year-over-year basis, and it expects conditions to improve. While that�� an expected statement from any company that�� performing poorly, and while Dendreon currently relies heavily on Provenge,�Dendreon isn�� a one-trick pony.�It still has several other drugs in the pipeline. It should also be noted that Dendreon has been on the brink of disaster many times throughout its history. It has clawed its way back to life in every instance. Perhaps it has nine lives. If that�� the case, it has used up four of them so far.

  • [By Johanna Bennett]

    Once, one of the hottest biotech stocks around, Dendreon (DNDN) has become a cautionary tale, warning investors what can happen when a cutting-edge�drug turns into a dud.

    Now at less than $3 a share, the stock had traded as high as $54 in 2010 as excitement buzzed over the�experimental prostate cancer vaccine Provenge. Initially, Wall Street expected peak sales of $3 billion to $4 billion. But insurers balked at the�hefty price tag for Provenge, and now, three years after it�won FDA approval, analysts see annual sales at roughly $300 million.

    Disappointing sales are just one reason Deutsche Bank has joined the�bearish�voices surrounding this drug maker.�Today, analyst Robyn Karnauskas downgraded Dendreon�to a Sell and cut the�price target to $1, warning that even if the company�can significantly reduce�costs and drastically restructures, its�spending may still outpace revenue growth in the short-term. Karnauskas believes Dendreon may have to refinance its debt, negatively impacting shareholders.

    Earlier this month, the company�posted a bigger-than-expected second-quarter loss as Provenge sales fell compared to last year. A restructuring plan was�unveiled in late July, though�analysts say it isn’t enough without revenue growth.�Today, Deutsche Bank’s Karnauskas writes:�

    …By our math, even with $165M in cost cuts, the co will have to grow current sales from $300M to $525M over next 7 years to support current share price. 2Q13 sales were $73M and DTC campaign does not seem to have a lot of effect to offset impact from competition so that the company could reach profitability in 4Q13. While they note that they plan to cut costs, we are concerned it may be too late. Revenue growth is not occurring quick enough; we note 1Q13 yoy growth was guided and in 2Q13 they noted this was unlikely to occur going fwd. The co�� inability to guide growth & provide visibility makes it difficult for us to see sales accelerating sufficiently in next 12-18 months to give equity & debt shareholders confidence.

    Today, Dendreon�� share price fell 10% to $2.87.

10 Best Biotech Stocks To Buy For 2014: Cannabis Science Inc (CBIS.PK)

Cannabis Science, Inc., incorporated on May 4, 2007, is a development-stage company. The Company is engaged in the creation of cannabis-based medicines, both with and without psychoactive properties, to treats disease and the symptoms of disease, as well as for general health maintenance. On February 9, 2012, the Company acquired GGECO University, Inc. (GGECO). On March 21, 2012, the Company acquired Cannabis Consulting Inc. (CCI Group).

The Company is engaged in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.